Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $134.8100 (-3.34%) ($134.8100 - $134.8100) on Sun. Oct. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.12% (three month average) | RSI | 48 | Latest Price | $134.8100(-3.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND advances 1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting LGND price | LGND will decline at least -1.56% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.56% (StdDev 3.12%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $137.43 | 5 Day Moving Average | $138.63(-2.76%) | 10 Day Moving Average | $139.09(-3.08%) | 20 Day Moving Average | $137.43(-1.91%) | To recent high | -5.2% | To recent low | 31.6% | Market Cap | $N/A | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |